AI-generated summary
In this pilot study, the authors examined transcranial photobiomodulation in 31 women with chemotherapy-related cognitive impairment, using the FACT-Cog questionnaire before and after 10 weekly sessions. The authors report that total FACT-Cog scores rose significantly after treatment, with 29 patients reporting improvement, and that the results suggest possible therapeutic promise.
- Participants
- 31
- Who or what was studied
- Women with chemotherapy-related cognitive impairment (chemobrain), mean age 52.1 years
- Limits stated in the abstract
- The abstract describes a pilot study with no control group and relies on self-reported cognitive measures.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Pilot study, Depression, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.